Sensex, Nifty 50 Close Lower But Outperform Asian Markets Amid Tariff
Sandip Raj Gupta
03/Apr/2025

-
Sensex fell 0.42% to 76,295, while Nifty 50 lost 0.38% but outperformed Asian peers.
-
Pharma stocks rallied as Trump exempted drug exports from tariffs.
-
Midcap & smallcap indices gained, with Nifty Smallcap 100 rising 0.58%.
Indian stock markets closed lower on April 3 but managed to outperform other Asian indices, as the US imposed a 26% tariff on Indian exports.
Market Performance Snapshot
-
Sensex fell 0.42% to 76,295 points
-
Nifty 50 dropped 0.38% to 23,243 points
-
Nifty Midcap 100 gained 0.26% to 52,186 points
-
Nifty Smallcap 100 rose 0.58% to 16,255 points
Why Did Indian Markets Perform Better?
Pharma Stocks Shine
-
Trump exempted drug exports from tariffs, boosting pharma stocks.
-
India’s pharma sector has massive exposure to the US market, driving gains.
India Among Least-Tariffed Asian Exporters
-
Trump’s 26% duty on India is lower than China (54%), Vietnam (46%), and Bangladesh (37%).
-
This could benefit Indian textile & EMS stocks as US buyers look for alternatives.
Broader Markets Show Strength
-
Midcaps & smallcaps gained, indicating domestic investor confidence.
-
Electronics & textile sectors saw buying interest, anticipating export opportunities.
Global Market Reaction
-
US markets faced selling pressure, as fears of a recession grew.
-
Asian indices dropped sharply, with China’s markets among the worst hit.
-
Supply chain disruptions, inflation risks, and trade tensions added to global uncertainty.
Defense & Engineering Stocks Gain
-
Kirloskar Oil Engines rose sharply after securing a ₹270 crore contract from the Indian Navy to design a 6MW medium-speed marine diesel engine under the Make-I initiative.
-
Bharat Electronics gained after receiving a ₹593.2 crore contract from the Indian Air Force for Akash Missile System maintenance.
-
Interarch Building advanced as it secured a ₹300 crore contract for pre-engineered steel building systems.
Pharma Stocks Surge Amid US Tariff Exemptions
-
Gland Pharma, Marksans Pharma, Aurobindo Pharma, and Lupin rose over 6% as the US exempted the pharmaceutical sector from the 27% reciprocal tariff on Indian imports.
-
The move provided relief to Indian pharma exporters, with domestic and global investors reacting positively.
Banking Stocks Rally on Strong Q4FY25 Performance
-
Punjab National Bank rose as its domestic business hit ₹25.8 lakh crore, up 13.2% YoY, while global deposits rose 14.3%.
-
IDFC First Bank surged as total deposits rose 22.7% YoY to ₹4.8 lakh crore, while loans and advances grew 20.3% YoY.
-
AU Small Finance Bank gained as total deposits surged 27.2% YoY, while gross advances grew 25.8% YoY.
-
Bank of Baroda climbed as global business grew 11.4% YoY to ₹27 lakh crore, with domestic deposits up 9.3% YoY.
Real Estate & Manufacturing Gains
-
Mahindra Lifespace Developers surged after securing the redevelopment of two societies in Andheri West, Mumbai, with expected sales revenue of ₹1,200 crore.
-
Gokaldas Exports soared as India's 27% reciprocal tariff on garments was the lowest among key exporters, compared to Vietnam (46%), Bangladesh (37%), and China (54%).
IT Stocks Decline Amid US Trade Concerns
-
TCS, Infosys, HCL Tech, and Tech Mahindra fell over 2.7% as concerns over higher US inflation led to fears of reduced IT spending by American firms.
-
The US 27% tariff hike on Indian exports could impact Indian IT companies, which rely heavily on US-based clients.
Chemical Stocks See Mixed Reactions
-
SRF and Navin Fluorine declined after higher US tariffs on chemicals raised concerns over Indian exports.
-
However, India's 27% tariff rate was similar to or lower than competitors like China (34%) and Japan (24%), offering a relative advantage.
Other Notable Stock Movements
-
Avanti Feeds plunged as the US imposed a 27% tariff on Indian shrimp imports, significantly impacting its North American revenue.
-
Dabur India fell sharply due to flat Q4 revenue growth and an expected margin decline of up to 175 bps.
-
Poonawalla Fincorp surged as assets under management rose 42.2% YoY to ₹35,550 crore.
-
Hero MotoCorp gained as monthly wholesales rose 12% YoY in March, supported by higher scooter sales and strong exports.
-
Bajaj Finance declined after receiving an RBI 'letter of displeasure' over co-branded credit card compliance issues.
-
Bharat Forge fell as its Class 8 truck orders in North America hit a seven-month low, dropping 14% YoY.
-
Tejas Networks continued its uptrend as BSNL expanded its 4G and 5G infrastructure, benefiting from its role as a key equipment supplier.
Economic & Policy Updates
-
The Indian government received a record ₹74,016.7 crore in dividend receipts from CPSEs in FY25, exceeding FY24's ₹63,749.3 crore.
-
JP Morgan reported that India's equity market is better positioned than other Asian markets to absorb the impact of US tariffs, as India’s exports to the US account for just 2% of its GDP.
The market remains highly volatile, with sectors reacting differently to global trade policies and corporate earnings.